{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T03:36:39Z","timestamp":1769398599500,"version":"3.49.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"26","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020540","name":"Coherus BioSciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020540","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.2217\/fon-2021-0532","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T15:13:00Z","timestamp":1625843580000},"page":"3485-3497","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Same-Day Versus Next-Day Pegfilgrastim or Pegfilgrastim-Cbqv in Patients with Lymphoma Receiving CHOP-Like Chemotherapy"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-4675","authenticated-orcid":false,"given":"Ali","family":"McBride","sequence":"first","affiliation":[{"name":"Banner University Medical Center,\rTucson, AZ85719, USA"},{"name":"Center for Health Outcomes & PharmacoEconomic Research, University of Arizona,\rTucson, AZ85721, USA"},{"name":"Department of Pharmacy Practice & Science,College of Pharmacy, University of Arizona,\rTucson, AZ85721, USA"},{"name":"University of Arizona Cancer Center,\rTucson, AZ85719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-1831","authenticated-orcid":false,"given":"Neda","family":"Alrawashdh","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes & PharmacoEconomic Research, University of Arizona,\rTucson, AZ85721, USA"},{"name":"Clinical Translational Sciences, College of Medicine, University of Arizona,\rTucson, AZ85724, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trace","family":"Bartels","sequence":"additional","affiliation":[{"name":"Banner University Medical Center,\rTucson, AZ85719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Moore","sequence":"additional","affiliation":[{"name":"Banner University Medical Center,\rTucson, AZ85719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Persky","sequence":"additional","affiliation":[{"name":"Banner University Medical Center,\rTucson, AZ85719, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0490-4421","authenticated-orcid":false,"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes & PharmacoEconomic Research, University of Arizona,\rTucson, AZ85721, USA"},{"name":"Department of Pharmacy Practice & Science,College of Pharmacy, University of Arizona,\rTucson, AZ85721, USA"},{"name":"University of Arizona Cancer Center,\rTucson, AZ85719, USA"},{"name":"Clinical Translational Sciences, College of Medicine, University of Arizona,\rTucson, AZ85724, USA"},{"name":"Matrix45,\rTucson, AZ85743, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology. Hematopoietic Growth Factors. Version 2.2021. (2021)."},{"key":"e_1_3_5_4_1","unstructured":"National Cancer Institute . Common Terminology Criteria for Adverse Events (CTCAE) version 3.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019588"},{"key":"e_1_3_5_6_1","unstructured":"US Bureau of Labor Statistics . CPI inflation calculator. https:\/\/www.bls.gov\/data\/inflation_calculator.htm"},{"key":"e_1_3_5_7_1","unstructured":"Federal Reserve Bank of St. Louis . Consumer price index for all urban consumers: medical care in U.S. city average (CPIMEDSL). https:\/\/fred.stlouisfed.org\/series\/CPIMEDSL"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325"},{"key":"e_1_3_5_9_1","unstructured":"Neulasta (pegfilgrastim) injection for subcutaneous use [package insert]. Amgen Inc CA USA (2021)."},{"key":"e_1_3_5_10_1","unstructured":"Fulphila (pegfilgrastim-jmdb) injection for subcutaneous use [package insert]. Mylan Institutional LLC IL USA (2021)."},{"key":"e_1_3_5_11_1","unstructured":"Udenyca (pegfilgrastim-cbqv) injection for subcutaneous use [package insert]. Coherus Biosciences CA USA (2021)."},{"key":"e_1_3_5_12_1","unstructured":"Ziextenzo (pegfilgrastim-bmez) injection for subcutaneous use [package insert]. Sandoz Inc NJ USA (2021)."},{"key":"e_1_3_5_13_1","unstructured":"Nyvepria (pegfilgrastim-apgf) injection for subcutaneous use [package insert]. Hospira Inc. a Pfizer Company IL USA (2021)."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.013"},{"key":"e_1_3_5_15_1","unstructured":"American Society of Clinical Oncology . Cancer treatment & supportive care. (2021). https:\/\/www.asco.org\/asco-coronavirus-resources\/care-individuals-cancer-during-covid-19\/cancer-treatment-supportive-care"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-3036-7"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1386858"},{"key":"e_1_3_5_18_1","unstructured":"National Comprehensive Cancer Network . NCCN hematopoietic growth factors. short-term recommendations specific to issues with COVID-19 (SARS-CoV-2). (2020)."},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2016.1257980"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.e18273"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1188\/17.CJON.121-122"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220956305"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.15.1201"},{"key":"e_1_3_5_24_1","unstructured":"Neupogen (filgrastim) injection for subcutaneous or intravenous use [package insert]. Amgen Inc CA USA (2021)."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4513-6"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.091094"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2970-5"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.4357.4357"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4373-0"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.e14510"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05982-0"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000115"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.4893"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2229"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000217816.16236.22"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.e18562"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1495621"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01459-y"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3703-y"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:55Z","timestamp":1719124975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":37,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.2217\/fon-2021-0532"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0532","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}